Clinical Trial Update: Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail [Phase 2]

View source ↗

Summary

Phase 2 trial update on NVXT Solution for mild-to-moderate fungal toenail infection (onychomycosis) completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• NVXT Solution

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Onychomycosis | Phase 2 | Status: COMPLETED | Results posted: 2018-08-22